Moreover, inhibition of NF-κB activity either through targeting RELA with shRNAs or treatment with inhibitor did not result in lung cancer cell senescence (Supplementary Figure 3H, 3I, 3J, 3K, and 3L), suggesting that NF-κB pathway is not involved in this process. Here, RELA is linked to lung carcinoma.